On Friday, Hims & Hers Health Inc (HIMS) stock saw a decline, ending the day at $19.32 which represents a decrease of $-1.53 or -7.34% from the prior close of $20.85. The stock opened at $21.34 and ...

Shares of Hims & Hers Health jumped after the company added former Food and Drug Administration official Deb Autor to its board. The stock was up 8.8% at $21.02 in Monday trading. Shares have doubled ...

Hims & Hers Health, announced Deb Autor, former deputy commissioner at the FDA, will join the company’s board of directors, and Janet ...

Hims & Hers offers personalized telehealth services, with a stock price that reflects high-growth potential. See why we ...

Amazon acquired primary care provider One Medical for $3.9 billion in 2022, and fills prescriptions through Amazon One ...

Hims & Hers Health Inc. shares tumbled 22% Thursday, on concerns that Amazon.com Inc.’s latest push into healthcare will ...

Health and wellness platform Hims & Hers Health, Inc. (NYSE:HIMS), which has gained traction for its obesity-related ...

Investors with a lot of money to spend have taken a bullish stance on Hims & Hers Health HIMS. And retail traders should know ...

Related reading: Hello Cake Review – Are Their Dissolvable ED Meds Legit? Sildenafil citrate (Generic Viagra ... minutes ...

Analyzing H&H's Q3 results and investment strategy in the healthcare industry, highlighting undervaluation and raising the ...

Hims & Hers Health (NYSE: HIMS) reported another blowout quarter recently, but the stock didn't get the type of pop that ...

Hims & Hers Health, Inc. (NYSE:HIMS) investors will be delighted, with the company turning in some strong numbers with its latest results. It was overall a positive result, with revenues beating ...